COVID-19

All Items

• A roadmap for kidney health for South Africa in the context of universal health coverage

  N Wearne, Y Chothia, F Bisiwe, B Cullis, R Freercks, V Rekhviashvili , S Wadee, M Davies, N Diana, M McCulloch, G Paget, W van Hougenhouck-Tulleken , Z Barday, L Jacobs, D Thomson, A Muranda

  e4086

• Thrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID-19 pandemic

  C-Y Wang, E Schapkaitz, S Louw, B Jacobson

  e3503

• The impact of the MMed research requirement on registrar training and specialist registration in South Africa: An internet e-survey

  B M Biccard, R A Dyer, J Fagan, N Vickery, J L Orrock

  e2788

• Clot twist – D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS

  F Patel, J le Roux, S Sawry, R Kieser , M Dhar , K Gill, E Lazarus, A Nana, N Garrett, P L Moore, A Sigal, G Gray , H V Rees, B F Jacobson, L Fairlie

  e3121

• Real-world effectiveness of Ad26.COV2.S or BNT162b2 booster vaccines against severe COVID-19 in adults who received a primary dose of Ad26.COV2.S in South Africa during the Delta period: A retrospective cohort study using medical scheme data

  L Fairall, N Yende-Zuma, Tarylee Reddy, N Garrett, A Goga, S Bennet, N Folb, I Seocharan, S Mametja, M Semenya, S R N Simelane, Prof. Linda-Gail Bekker, G E Gray

  e2532

• Access to oncology care in western KwaZulu-Natal Province before, during and after the COVID-19 pandemic

  L Walker, L Stopforth, L Naidoo, S Ferrer

  e2665

• Diarrhoeal admissions among children aged <5 years in public sector facilities in Western Cape Province, South Africa, before and during the COVID-19 pandemic (2019 - 2021)

  K Kehoe, E Morden, N Zinyakatira, A Heekes, H E Jones, S R Walter, T Jacobs, J Murray, H Buys, B Eley, T Redaniel, M-A Davies

  e2726

• High frequency of SARS-CoV-2 infection in children admitted to academic hospitals in central South Africa

  O P Khaliq, S C Brown, B Pitso, N E Tabane

  e2969

• The COVID-19 pandemic and blood utilisation in South Africa

  R Swanevelder, P-L Wessels; V J Louw; A Swarts, M Lennards, K van den Berg

  e2001

• The impact of COVID-19 on patients affected by rare diseases and congenital disorders in South Africa: A scoping review

  M C M Gomes, H L Malherbe

  e1795

• The Ministerial Advisory Committees and 3 years of COVID-19 expertise – is the Department of Health’s model for information-sharing pandemic-ready?

  M Richter, Y Nokhepheyi

  e1943

• The prevalence and distribution of malaria in Mpumalanga Province before and during COVID-19 (2017 - 2022)

  I Kleinhans, S Mahanjana, F Els, M Mabona, L A Pitso, G Malatje, G Kok, J Raman

  e1736

• Registered COVID deaths in South Africa during the first year of the SARS-CoV-2 epidemic

  T A Moultrie, R Dorrington, D Bradshaw, P Groenewald

  e2269

• The pattern of antibiotic utilisation among intensive care unit patients hospitalised in a Gauteng (South African) provincial tertiary hospital: Comparing findings before and during COVID-19

  L Spinickum, Z Booth, S Leigh-de Rapper

  e1812

• Resilience in the time of crisis: A review of the maternal, perinatal and reproductive health effects of COVID-19 in South Africa

  S Fawcus, S Gebhardt, R Niit, R Pattinson

  e1757

• Clinical course, management and outcomes of COVID-19 in HIV-infected renal transplant recipients: A case series

  L Bertels, K Manning, A Redd, T du Toit, Z Barday, E Muller

  e1374

• Household transmission of SARS-CoV-2 in a rural area in South Africa

  G Maimela, C E Martin, M Chersich, B Bello, J Mauti, T Bäernighausen, S Kohler, A Almuedo-Riera, S Luchters, S Sawry

  e1159

• Mortality trends during the first three waves of the COVID-19 pandemic at an urban district hospital in South Africa: A retrospective comparative analysis

  O Hirachund, C Pennefather, M Naidoo

  e1054

• An outbreak within an outbreak: The impact of Infection Prevention and Control strategies on hospital-acquired infections and the occurrence of multi-drug resistant organisms during the COVID-19 pandemic

  B Mashigo, A Parker, U Lalla, B W Allwood, M S Moolla, T Lovelock, C F N Koegelenberg

  42

• Antivirals for the treatment of mild and moderate COVID-19 in South Africa

  R Perumal, V Naidoo, S Govender, T N Gengiah

  33

• Prevalence of comorbid disease and associated risk factors among homeless people living in temporary shelters during the COVID-19 lockdown in Tshwane, South Africa

  T V Phiri, N Gloeck, A Musekiwa

  48-52

• Investigating blood alcohol concentrations in injury-related deaths before and during the COVID-19 National lockdown in Western Cape, South Africa: A cross-sectional retrospective review

  V Bachan, I Molefe, B Davies

  50-56

• Ivermectin drug induced liver injury

  Mark Sonderup, Washington Mudini, Wendy Spearman

  24-25

• Correspondence and reply Practising in a post-truth world: – truth revision

  Boitumelo Semete-Makokotlela, Andy Parish, Andy Gray, Marc Blockman, Helen Rees